Novartis AG, Johnson & Johnson Services, Inc. and ZEISS International are Dominating the Global Ophthalmic Surgical Instruments Market in 2018

Global Ophthalmic Surgical Instruments Market

Novartis AG:

Novartis AG was incorporated in 1996 and headquartered at Basel, Switzerland. The company is engaged in research, development, manufacturing and marketing of healthcare products. It has its global networks through direct sales representatives and distributors in the Americas, Europe, Asia/Africa/Australasia. The company has various subsidiaries such as Sandoz (Germany), Alcon (U.S.), AveXis (U.S.), Endocyte (Indiana), Hexal AG (Germany) and others.

Access Full Report at https://databridgemarketresearch.com/reports/global-ophthalmic-surgical-instruments-market

  • In November 2018, Alcon the division of the Novartis AG expanded their community to help and support the eye care professionals with the launch of lcon Retina Fellows Institute, which is a unique educational platform in the U.S.

Johnson & Johnson Services, Inc.:

Founded in 1886 and headquarter at New Jersey, U.S. Johnson & Johnson Services, Inc. is focused to improve access and affordability, create healthier community and to reach everyone and everywhere. The company operates through three main segments, namely, pharmaceutical, medical devices and consumer. It has its global networks through direct sales representatives and distributors in the Europe, Western Hemisphere, Asia-Pacific, Africa and the U.S. It operates through its subsidiaries such as Janssen Global Services, LLC (Belgium), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.), Janssen Global Services, LLC, (Belgium) among others.

  • In February 2017, Johnson & Johnson announced acquisition with the Abbott Medical Optics (AMO), a subsidiary of Abbott (U.S.). The acquisition includes the transaction of cash USD 4.325 billion and the acquisition will help the company to incorporate the eye care division such as cataract surgery, laser refractive surgery and consumer eye health.

ZEISS International:

Established in 1846 and headquarter at Oberkochen, Germany. The company is engaged in developing, producing and distributing highly innovative solutions for various industries. It has its global networks through direct sales representatives and distributors in the EMEA (without Germany), APAC, Americas and Germany. It operates through its subsidiaries such as Carl Zeiss Meditec AG (Germany), Carl Zeiss Laser Optics Gmbh (Germany), Carl Zeiss SMT GmbH (Germany), Carl Zeiss Vision Holding GmbH (Germany) and Brock & Michelsen A/S (Denmark).

  • In November 2018, ZEISS International announced the collaboration with Inscopix (U.S.). The collaboration is to provide joint workflow for the development of high resolution and freely behaving signaling data that ensures benefit in the functional neuroscience.